New Risk • May 11
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 6.4% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.4% operating cash flow to total debt). Earnings have declined by 31% per year over the past 5 years. New Risk • May 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 21% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change). 공시 • Mar 31
Malion New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 23, 2026 Malion New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026 Reported Earnings • Mar 31
Full year 2025 earnings released: CN¥0.099 loss per share (vs CN¥0.05 profit in FY 2024) Full year 2025 results: CN¥0.099 loss per share (down from CN¥0.05 profit in FY 2024). Revenue: CN¥1.66b (down 3.8% from FY 2024). Net loss: CN¥70.4m (down 297% from profit in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance. 공시 • Mar 31
Malion New Materials Co., Ltd., Annual General Meeting, Apr 20, 2026 Malion New Materials Co., Ltd., Annual General Meeting, Apr 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shantou, Guangdong China 공시 • Dec 31
Malion New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026 Malion New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026 Reported Earnings • Oct 25
Third quarter 2025 earnings released: CN¥0.029 loss per share (vs CN¥0.003 profit in 3Q 2024) Third quarter 2025 results: CN¥0.029 loss per share (down from CN¥0.003 profit in 3Q 2024). Revenue: CN¥369.6m (down 11% from 3Q 2024). Net loss: CN¥21.0m (down CN¥23.0m from profit in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance. 공시 • Sep 30
Malion New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 25, 2025 Malion New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025 New Risk • Sep 03
New major risk - Revenue and earnings growth Earnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.2% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change). New Risk • Aug 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). 공시 • Jul 02
Malion New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 27, 2025 Malion New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 27, 2025 Reported Earnings • Apr 24
First quarter 2025 earnings released: EPS: CN¥0.013 (vs CN¥0.037 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.013 (down from CN¥0.037 in 1Q 2024). Revenue: CN¥447.7m (up 6.5% from 1Q 2024). Net income: CN¥9.40m (down 65% from 1Q 2024). Profit margin: 2.1% (down from 6.3% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. 공시 • Apr 23
Malion New Materials Co., Ltd., Annual General Meeting, May 13, 2025 Malion New Materials Co., Ltd., Annual General Meeting, May 13, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shantou, Guangdong China 공시 • Mar 31
Malion New Materials Co., Ltd. to Report Q1, 2025 Results on Apr 23, 2025 Malion New Materials Co., Ltd. announced that they will report Q1, 2025 results on Apr 23, 2025 공시 • Jan 24
Malion New Materials Co., Ltd. Announces Board Appointments Malion New Materials Co., Ltd. announced at the EGM held on January 22, 2025, approved election of Huang Kunyu as non-independent director; Shen Yiyong and Chen Xiaowei as independent director. Board Change • Jan 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 2 highly experienced directors. Independent Director Yiping Rui was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. 공시 • Dec 31
Malion New Materials Co., Ltd. to Report Fiscal Year 2024 Results on Apr 23, 2025 Malion New Materials Co., Ltd. announced that they will report fiscal year 2024 results on Apr 23, 2025 New Risk • Nov 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Profit margins are more than 30% lower than last year (2.9% net profit margin). 공시 • Nov 22
Malion New Materials Co., Ltd. (SZSE:300586) and Yingkou Shenghai Investment Co., Ltd. signed Equity Transfer Agreement to acquire an additional 26.84% stake in Yingkou Yingxin Chemical Technology Co., Ltd. from Shandong Sinobioway Tianyuan Biotechnology Co., Ltd. for CNY 26.8 million. Malion New Materials Co., Ltd. (SZSE:300586) and Yingkou Shenghai Investment Co., Ltd. signed Equity Transfer Agreement to acquire an additional 26.84% stake in Yingkou Yingxin Chemical Technology Co., Ltd. from Shandong Sinobioway Tianyuan Biotechnology Co., Ltd. for CNY 26.8 million on November 19, 2024. A cash consideration of CNY 74.03 million will be paid by Malion New Materials Co., Ltd. and Yingkou Shenghai Investment Co., Ltd. Upon completion, Malion New Materials Co., Ltd. will own 49.89% and Yingkou Shenghai Investment Co., Ltd. will own 31.06% stake in Yingkou Yingxin Chemical Technology Co., Ltd.
As of June 30, 2024, Yingkou Yingxin Chemical Technology Co., Ltd. reported total assets of CNY 573.14 million and total common equity of CNY 336.05 million. The transaction is subject to approval of merger agreement by target board. The deal has been approved by the board. Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.003 (vs CN¥0.015 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.003 (down from CN¥0.015 in 3Q 2023). Revenue: CN¥417.4m (down 2.5% from 3Q 2023). Net income: CN¥1.99m (down 82% from 3Q 2023). Profit margin: 0.5% (down from 2.5% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. 공시 • Sep 30
Malion New Materials Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Malion New Materials Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. 공시 • Jun 29
Malion New Materials Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Malion New Materials Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥6.51, the stock trades at a trailing P/E ratio of 52.7x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 2.7% over the past three years. 공시 • May 25
Malion New Materials Co., Ltd. Announces Cash Dividend for the Year 2023, Payable on 30 May 2024 Malion New Materials Co., Ltd. announced the 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included) of CNY 0.50000000. Record date: 29 May 2024. Ex-date: 30 May 2024. Payment date: 30 May 2024. 공시 • Apr 30
Malion New Materials Co., Ltd., Annual General Meeting, May 20, 2024 Malion New Materials Co., Ltd., Annual General Meeting, May 20, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shantou, Guangdong China Reported Earnings • Apr 29
First quarter 2024 earnings released: EPS: CN¥0.037 (vs CN¥0.079 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.037 (down from CN¥0.079 in 1Q 2023). Revenue: CN¥420.2m (down 20% from 1Q 2023). Net income: CN¥26.5m (down 51% from 1Q 2023). Profit margin: 6.3% (down from 10% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥6.81, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 14% over the past three years. New Risk • Apr 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (8.3% net profit margin). Valuation Update With 7 Day Price Move • Apr 02
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥7.99, the stock trades at a trailing P/E ratio of 33.9x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 27% over the past three years. 공시 • Mar 30
Malion New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024 Malion New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024 Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥5.82, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 1.4% over the past three years. 공시 • Dec 30
Malion New Materials Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024 Malion New Materials Co., Ltd. announced that they will report fiscal year 2023 results on Apr 29, 2024 Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.015 (vs CN¥0.084 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.015 (down from CN¥0.084 in 3Q 2022). Revenue: CN¥427.9m (down 19% from 3Q 2022). Net income: CN¥10.8m (down 81% from 3Q 2022). Profit margin: 2.5% (down from 11% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Price Target Changed • Sep 01
Price target decreased by 7.9% to CN¥8.50 Down from CN¥9.23, the current price target is provided by 1 analyst. New target price is 18% below last closing price of CN¥10.36. Stock is down 27% over the past year. The company is forecast to post earnings per share of CN¥0.73 for next year compared to CN¥0.47 last year. Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.15 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.051 (down from CN¥0.15 in 2Q 2022). Revenue: CN¥444.0m (down 31% from 2Q 2022). Net income: CN¥36.4m (down 64% from 2Q 2022). Profit margin: 8.2% (down from 16% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 28
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥12.39, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 83% over the past three years. Price Target Changed • Apr 27
Price target decreased by 23% to CN¥7.10 Down from CN¥9.23, the current price target is provided by 1 analyst. New target price is 34% below last closing price of CN¥10.80. Stock is up 38% over the past year. The company is forecast to post earnings per share of CN¥0.68 for next year compared to CN¥0.47 last year. Reported Earnings • Mar 29
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥0.60 (up from CN¥0.13 in FY 2021). Revenue: CN¥2.40b (up 28% from FY 2021). Net income: CN¥317.1m (up 401% from FY 2021). Profit margin: 13% (up from 3.4% in FY 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 9.8%. Earnings per share (EPS) also missed analyst estimates by 5.5%. Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Mar 10
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 15%. The fair value is estimated to be CN¥22.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 57% in 2 years. Earnings is forecast to grow by 67% in the next 2 years. 공시 • Dec 28
Malion New Materials Co., Ltd. announced that it has received CNY 465.538996 million in funding On December 27, 2022, Malion New Materials Co., Ltd. closed the transaction. The company issued 68,461,617 shares, par value CNY 1 per share, at an issue price of CNY 6.80 per share for gross proceeds of CNY 465,538,995.60. The transaction included participation from 11 investors. The company raised CNY 457,549,880.87 after deducting issuance expenses of CNY 7,989,114.73. The transaction has been approved by the China Securities Regulatory Commission. Buying Opportunity • Dec 06
Now 21% undervalued Over the last 90 days, the stock is up 8.5%. The fair value is estimated to be CN¥27.56, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 60% in 2 years. Earnings is forecast to grow by 100% in the next 2 years. Valuation Update With 7 Day Price Move • Nov 21
Investor sentiment improved over the past week After last week's 27% share price gain to CN¥21.45, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 205% over the past three years. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non Independent Director Haijiao Liu was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.013 loss in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.11 (up from CN¥0.013 loss in 3Q 2021). Revenue: CN¥526.2m (up 32% from 3Q 2021). Net income: CN¥57.5m (up CN¥64.3m from 3Q 2021). Profit margin: 11% (up from net loss in 3Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 36% per year whereas the company’s share price has increased by 39% per year. Valuation Update With 7 Day Price Move • Oct 12
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥19.70, the stock trades at a trailing P/E ratio of 44.3x. Average trailing P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 166% over the past three years. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.006 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.006 in 2Q 2021). Revenue: CN¥641.0m (up 67% from 2Q 2021). Net income: CN¥101.8m (up CN¥99.2m from 2Q 2021). Profit margin: 16% (up from 0.7% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥16.99, the stock trades at a trailing P/E ratio of 66.4x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 138% over the past three years. Valuation Update With 7 Day Price Move • May 03
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥10.25, the stock trades at a trailing P/E ratio of 40.1x. Average trailing P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years. Reported Earnings • Apr 28
First quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.044 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.17 (up from CN¥0.044 in 1Q 2021). Revenue: CN¥610.3m (up 36% from 1Q 2021). Net income: CN¥90.9m (up 354% from 1Q 2021). Profit margin: 15% (up from 4.5% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Board Change • Apr 27
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non Independent Director Dongsheng Yi was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 18
Full year 2021 earnings released: EPS: CN¥0.13 (vs CN¥0.09 in FY 2020) Full year 2021 results: EPS: CN¥0.13 (up from CN¥0.09 in FY 2020). Revenue: CN¥1.88b (up 24% from FY 2020). Net income: CN¥64.2m (up 53% from FY 2020). Profit margin: 3.4% (up from 2.8% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Board Change • Jan 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non Independent Director Dongsheng Yi was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Dec 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Independent Director Jin Jiang was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Oct 21
Third quarter 2021 earnings released: CN¥0.013 loss per share (vs CN¥0.029 profit in 3Q 2020) The company reported a soft third quarter result with weaker earnings and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: CN¥398.6m (up 12% from 3Q 2020). Net loss: CN¥6.82m (down 151% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Reported Earnings • Aug 29
Second quarter 2021 earnings released: EPS CN¥0.006 (vs CN¥0.087 in 2Q 2020) The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: CN¥383.5m (flat on 2Q 2020). Net income: CN¥2.59m (down 93% from 2Q 2020). Profit margin: 0.7% (down from 10% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. 공시 • May 21
Malion New Materials Co., Ltd. Approves Cash Dividend for 2020 Malion New Materials Co., Ltd. approved Cash dividend of CNY 0.00000000 per 10 shares (tax included) for 2020, at the AGM held on May 18, 2021. Reported Earnings • Apr 30
First quarter 2021 earnings released: EPS CN¥0.044 (vs CN¥0.032 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥449.1m (up 23% from 1Q 2020). Net income: CN¥20.0m (up 48% from 1Q 2020). Profit margin: 4.5% (up from 3.7% in 1Q 2020). 공시 • Feb 04
Malion New Materials Co., Ltd. (SZSE:300586) completed the acquisition of 51% stake in Chengdu First New Materials Co., Ltd from Peng Zhiyuan. Malion New Materials Co., Ltd. (SZSE:300586) signed an Equity Transfer Agreement to acquire 51% stake in Chengdu First New Materials Co., Ltd from Peng Zhiyuan for CNY 18.7 million on January 21, 2021. After transaction Peng Zhiyuan will hold 47%, Xue Yan will hold 2% and Malion New Materials will hold 51% stake in Chengdu First. As of September 30, 2020, Chengdu First had total assets of CNY 31.2 million and net assets of CNY 29.6 million. The transaction has been approved by the Malion New’s chairman and does not need to be submitted to the Malion New’s board of directors and the shareholders’ meeting for review and approval.
Malion New Materials Co., Ltd. (SZSE:300586) completed the acquisition of 51% stake in Chengdu First New Materials Co., Ltd from Peng Zhiyuan on February 2, 2021. Is New 90 Day High Low • Feb 04
New 90-day low: CN¥7.46 The company is down 36% from its price of CN¥11.72 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. Valuation Update With 7 Day Price Move • Jan 13
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥7.51, the stock is trading at a trailing P/E ratio of 46.8x, down from the previous P/E ratio of 55.8x. This compares to an average P/E of 34x in the Chemicals industry in China. Total returns to shareholders over the past three years are 38%. Is New 90 Day High Low • Jan 13
New 90-day low: CN¥7.51 The company is down 31% from its price of CN¥10.90 on 15 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥7.97, the stock is trading at a trailing P/E ratio of 49.7x, down from the previous P/E ratio of 59.7x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 54%. Is New 90 Day High Low • Dec 28
New 90-day low: CN¥9.29 The company is down 6.0% from its price of CN¥9.87 on 29 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥10.10, the stock is trading at a trailing P/E ratio of 63x, down from the previous P/E ratio of 74.5x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past three years are 72%. Valuation Update With 7 Day Price Move • Dec 02
Market bids up stock over the past week After last week's 29% share price gain to CN¥12.29, the stock is trading at a trailing P/E ratio of 76.6x, up from the previous P/E ratio of 59.3x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 138%. Is New 90 Day High Low • Nov 25
New 90-day low: CN¥9.52 The company is down 13% from its price of CN¥10.99 on 28 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. Reported Earnings • Oct 29
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥72.3m, down 31% from the prior year. Total revenue was CN¥1.48b over the last 12 months, up 39% from the prior year. Is New 90 Day High Low • Oct 29
New 90-day high: CN¥11.61 The company is up 29% from its price of CN¥8.99 on 30 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. 공시 • Aug 13
Malion New Materials Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020 Malion New Materials Co., Ltd. announced that they will report first half, 2020 results on Aug 28, 2020 공시 • Aug 11
Malion New Materials Co., Ltd. announced that it expects to receive CNY 465.539 million in funding Malion New Materials Co., Ltd. (SZSE:300586) announced a private placement of not more than 136,800,000 A shares for gross proceeds of not more than CNY 465,539,000 on August 7, 2020. The transaction will include participation from not more than 5 investors. The issue price of the share will not be less than 80% of the average price in the 20 trading days before the pricing reference date. The shares are subject to 6 month hold period from the issuance closing date. The transaction has been approved in the 23rd meeting of the company's 3rd directorate of the company. The transaction is subject to approval from the shareholders’ meeting, Shenzhen Stock Exchange, and China Securities Regulatory Commission. 